Schizophrenia Researchers Striving for Early Detection and Intervention
Article Abstract:
Researchers continue to search for ways to identify children and teenagers at risk of schizophrenia so they can be treated early in the disease. Some studies showed that early detection methods can bring patients in for treatment more than one year earlier than usual. People with a susceptibility to schizophrenia may exhibit symptoms such as suspiciousness, depression, anger, difficulties with concentration or memory or the emergence of odd beliefs, a loss of energy or motivation, disturbances in perception, and social withdrawal. Once these people are identified, they can be treated with low-dose antipsychotic medications.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Delay in Treating Schizophrenia May Narrow Therapeutic Window of Opportunity
Article Abstract:
Schizophrenics who are treated shortly after they begin experiencing symptoms may have a better prognosis than those treated later. Researchers have also discovered that some of the newer antipsychotic drugs may even protect the brain from further damage. They also have fewer adverse effects than older drugs, which means that patients will be more likely to take the drug regularly. Many patients may also benefit from psychotherapy.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Progress Treating, Preventing Influenza
Article Abstract:
Two drugs appear to be effective in treating influenza. Zanamivir and GS4104 both inhibit a viral enzyme called neuraminidase, which is essential in allowing the virus to spread. These drugs are effective against both influenza A and B virus. The drugs may also be effective in preventing influenza. The best protection against influenza is still a vaccine, and researchers have developed a nasal spray vaccine called FluMist.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: A guide to nurse prescribing of insecticides and anthelmintics. Are you up to scratch?
- Abstracts: Know how. Silver dressings: Absorption and antibacterial efficacy. When and how to use adhesive film dressings
- Abstracts: Is cancer a disease of self-seeding? Tumor metastasis: Mechanistic insights and clinical challenges. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis
- Abstracts: Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. High-sensitivity immunoflourescence for detection of the pro- and anti-inflammatory cytokines gamma interferon and interleukin-10 on the surface of cytokine-secreting cells
- Abstracts: The acute respiratory distress syndrome. Acute pulmonary edema. Severe sepsis a new treatment with both anticoagulant and antiinflammatory properties